Spruce Biosciences, Inc.

Historical 13F Holders

Symbol
SPRB
CUSIP
85209E109
All holders as of
Q2 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 85209E109 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
RiverVest Venture Fund III, L.P. 13D/A
4.2% 1/10/2025
Event 1/7/2025
Radoff Bradley Louis 13G/A
0% 8/13/2025
Event 6/30/2025
Rock Springs Capital Management LP 13G/A
0% 8/13/2025
Event 7/3/2025
Rosalind Advisors, Inc. 13G/A
0% 2/13/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 3 2.05 M $147 k
2025 Q1 32 10.5 M $3.03 M
2024 Q4 32 11.2 M $4.69 M
2024 Q3 35 13.6 M $6.41 M
2024 Q2 45 16.6 M $8.61 M
2024 Q1 58 18.0 M $14.2 M
2023 Q4 43 32.3 M $94.4 M
2023 Q3 42 31.9 M $72.0 M
2023 Q2 41 32.0 M $68.8 M
2023 Q1 45 33.8 M $74.5 M
2022 Q4 33 18.3 M $20.1 M
2022 Q3 37 18.0 M $24.7 M
2022 Q2 40 16.4 M $28.5 M
2022 Q1 44 17.1 M $34.4 M
2021 Q4 52 17.7 M $79.1 M
2021 Q3 45 19.6 M $118 M
2021 Q2 42 20.1 M $225 M
2021 Q1 41 18.9 M $313 M
2020 Q4 46 18.9 M $459 M